Cargando…

Profile of alisporivir and its potential in the treatment of hepatitis C

Two classes of hepatitis C antiviral agents currently exist, ie, direct-acting antivirals and host-targeting antivirals. Direct-acting antivirals target viral proteins including NS3/NS4A protease, NS5B polymerase and NS5A protein, while host-targeting antivirals target various host proteins critical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallay, Philippe A, Lin, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578503/ https://www.ncbi.nlm.nih.gov/pubmed/23440335 http://dx.doi.org/10.2147/DDDT.S30946

Ejemplares similares

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
por: Coelmont, Lotte, et al.
Publicado: (2010)

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
por: Hopkins, Sam, et al.
Publicado: (2012)

Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)
por: Softic, Laurent, et al.
Publicado: (2020)

Alisporivir Normalizes Mitochondrial Function of Primary Mouse Lung Endothelial Cells Under Conditions of Hyperglycemia
por: Starinets, Vlada S., et al.
Publicado: (2022)

Effect of the MPT Pore Inhibitor Alisporivir on the Development of Mitochondrial Dysfunction in the Heart Tissue of Diabetic Mice
por: Belosludtseva, Natalia V., et al.
Publicado: (2021)

Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis
por: Dubinin, Mikhail V., et al.
Publicado: (2021)

Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient mdx Mice
por: Dubinin, Mikhail V., et al.
Publicado: (2021)

Alisporivir Treatment Alleviates Mitochondrial Dysfunction in the Skeletal Muscles of C57BL/6NCrl Mice with High-Fat Diet/Streptozotocin-Induced Diabetes Mellitus
por: Belosludtsev, Konstantin N., et al.
Publicado: (2021)

Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model
por: de Wilde, Adriaan H., et al.
Publicado: (2017)

The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation
por: Esser-Nobis, Katharina, et al.
Publicado: (2016)

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2014)

Development of a Flow Cytometry Live Cell Assay for the Screening of Inhibitors of Hepatitis C Virus (HCV) Replication
por: Garcia-Rivera, Jose A, et al.
Publicado: (2012)

Profile of perampanel and its potential in the treatment of partial onset seizures
por: Rheims, Sylvain, et al.
Publicado: (2013)

Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
por: Childs-Kean, Lindsey M, et al.
Publicado: (2019)

Spotlight on grazoprevir–elbasvir once-daily combination and its potential in the treatment of hepatitis C
por: Suraweera, Duminda, et al.
Publicado: (2016)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
por: Gowin, Krisstina L, et al.
Publicado: (2015)

Tenofovir and its potential in the treatment of hepatitis B virus
por: Reynaud, Laura, et al.
Publicado: (2009)

Profile of minocycline and its potential in the treatment of schizophrenia
por: Zhang, Lulu, et al.
Publicado: (2014)

Profile of selumetinib and its potential in the treatment of melanoma
por: Kim, Dae Won, et al.
Publicado: (2014)

Profile of lebrikizumab and its potential in the treatment of asthma
por: Maselli, Diego Jose, et al.
Publicado: (2015)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

Profile of evolocumab and its potential in the treatment of hyperlipidemia
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
por: Lin, Kai, et al.
Publicado: (2013)

Patient adherence issues in the treatment of hepatitis C
por: Larrey, Dominique, et al.
Publicado: (2014)

Profile of certolizumab and its potential in the treatment of psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2013)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease
por: Novakovic, Dijana, et al.
Publicado: (2013)

Profile of pacritinib and its potential in the treatment of hematologic disorders
por: Hatzimichael, Eleftheria, et al.
Publicado: (2014)

Profile of veliparib and its potential in the treatment of solid tumors
por: Wagner, Lars M
Publicado: (2015)

Profile of bevacizumab and its potential in the treatment of cervical cancer
por: Fisher, Christine M, et al.
Publicado: (2015)

Profile of farletuzumab and its potential in the treatment of solid tumors
por: Sato, Seiya, et al.
Publicado: (2016)

Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger, Katharina, et al.
Publicado: (2015)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

Profile of abemaciclib and its potential in the treatment of breast cancer
por: Martin, James M, et al.
Publicado: (2018)

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim, Shaheen P, et al.
Publicado: (2013)

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer
por: Davidson, Brittany A, et al.
Publicado: (2014)

Profile of efraloctocog alfa and its potential in the treatment of hemophilia A
por: George, Lindsey A, et al.
Publicado: (2015)

Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma
por: Hirte, Hal W
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k0cm4csafjot37enbhoue1vk1o